AP3B1 and COVID-19: In the lung, the loss of AP-3-mediated trafficking of lamellar bodies in surfactant-producing alveolar type 2 cells contributes to a gain of function that results in the enhanced activation of repair pathways associated with pulmonary fibrosis in HPS2 [22], which is also a key feature of severe COVID-19.